Long-term outcomes of a bioactive matrix enriched with an autologous platelet concentrate for the treatment of complex anal fistulae
This pilot study demonstrated that nearly half of the patients treated with RFT for CAF achieved long-term healing, with no adverse effects on continence and an excellent safety profile. Larger studies are needed to draw definitive conclusions.
Authors
- I.D. Maya (ORCID: https://orcid.org/0009-0004-1310-8085)
- Marc Martí (ORCID: https://orcid.org/0000-0002-0783-6359)
- Arturo Cirera de Tudela (ORCID: https://orcid.org/0000-0002-4972-5315)
- Gianluca Pellino (ORCID: https://orcid.org/0000-0002-8322-6421)
- Elvira Spada
- Eloy Espín (ORCID: https://orcid.org/0000-0002-9139-4548)
Institutions
- Hebron University (PS)
- Universitat Autònoma de Barcelona (ES)
- Vall d'Hebron Institut de Recerca (ES)
Publication Details
- Journal
- Techniques in Coloproctology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1007/s10151-024-03102-2
- Primary Topic
- Anorectal Disease Treatments and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00